Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2014 · 10-Q
Revenue$21.09K$21.09K−82.4% vs Q2 2013 Net Income-$826.46K-$826.46KN/M vs Q2 2013 EPS Diluted-$0.01-$0.01N/M vs Q2 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$452,199N/M Margins · derivedGross margin41.3%−51.2 pt vs Q2 2013
Operating margin-3952.5%−3524.0 pt vs Q2 2013
Net margin-3919.5%−3470.4 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 15, 2014 · 46 d after period end